Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes

Trends in Pharmacological Sciences

Volumn 24, Issue 9, 2003, Pages 441-443

  Jope, Richard S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LITHIUM; PHOSPHOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

CELL STRUCTURE; CELL SURVIVAL; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0042379932     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00206-2     Document Type: Short Survey

References (26)

1. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry. 4:1999;117-128.
2. Phiel C.J., Klein P.S. Molecular targets of lithium action. Annu. Rev. Pharmacol. Toxicol. 41:2001;789-813.
3. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8455-8459.
4. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280:2001;720-725.
5. De Sarno P., et al. Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium. Neuropharmacology. 43:2002;1158-1164.
6. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/ threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8745-8750.
7. Mora A., et al. Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell. Signal. 14:2002;557-562.
8. Song L., et al. Central role of glycogen synthase kinase-3β in endoplasmic reticulum stress-induced caspase-3 activation. J. Biol. Chem. 277:2002;44701-44708.
9. Zhang, F. et al. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: evidence for autoregulation of GSK-3. J. Biol. Chem. (in press).
10. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65:2001;391-426.
11. Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2:2001;769-776.
12. Kalderon D. Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol. 12:2002;523-531.
13. Beffert U., et al. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3β J. Biol. Chem. 277:2002;49958-49964.
14. Johnson G.V.W., Bailey C.D. Tau, where are we now? J. Alzheimers Dis. 4:2002;375-398.
15. Morfini G., et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 21:2002;281-293.
16. Eickholt B.J., et al. An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J. Cell Biol. 157:2002;211-217.
17. Etienne-Manneville S., Hall A. Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity. Nature. 421:2003;753-756.
18. Chuang D.M., et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 4:2002;129-136.
19. Li X., et al. Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection. Bipolar Disord. 4:2002;137-144.
20. Perez M., et al. Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase-3. Biochem. J. 372:2003;129-136.
21. Everall I.P., et al. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol. Cell. Neurosci. 21:2002;493-501.
22. Watcharasit P., et al. Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7951-7955.
23. Cross D.A., et al. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77:2001;94-102.
24. Kim J.W., et al. Glycogen synthase kinase 3β is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J. Biol. Chem. 278:2003;13995-14001.
25. Pap M., Cooper G.M. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β signaling pathway. Mol. Cell. Biol. 22:2002;578-586.
26. Phiel C.J., et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides. Nature. 423:2003;435-439.